Inogen, an oxygen supply device manufacturer, is notifying 30,000 existing and former customers their personal data may have been improperly accessed, Reuters reports. An unauthorized party may have ...
Inogen Inc ( (INGN)) has released its Q3 earnings. Here is a breakdown of the information Inogen Inc presented to its investors. Inogen, Inc. is a global medical technology company specializing in ...
Zacks.com on MSN
Papa John's (PZZA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
The market expects Papa John's (PZZA) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook ...
Inogen, Inc. INGN incurred an adjusted loss per share of 2 cents for third-quarter 2025, which was narrower than the adjusted loss per share of 11 cents in the year-ago period and the Zacks Consensus ...
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (INGN) (Nasdaq: INGN), a leading medical technology company offering innovative respiratory products for use in the homecare setting, today announced the ...
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report third quarter 2025 financial ...
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of ...
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (INGN) (Nasdaq: INGN), a leading medical technology company specializing in innovative respiratory products for homecare use, today announced the launch ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of ...
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction ...
Inogen also announced that, based on preliminary, unaudited financial information, the Company expects total revenue for the first quarter of 2021 to be in the range of $84.0 million to $87.0 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results